Bladder cancer
Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBCCase 1: Carl (64 years old)
Carl, a 64-year-old IT analyst, develops videogames as a hobby. His latest game is about a gnome who has to collect as many carrots as possible in a post-apocalyptic world where rabbits dominate the world.
He presented with episodes of macroscopic haematuria evolving for 1 year.
Assessment summary:
- Medical history:
- Diabetes, treated with metformin
- Hypertension, treated with ramipril
- Former smoker (30 years)
- Family history: sister with breast cancer, uncle with colon cancer
- Creatinine level: 55 µmol/l, estimated GFR (eGFR): 105 ml/min
- MRI: bladder polyp
- CT urogram: no concomitant upper tract tumour
- Transurethral resection of bladder tumour (TURBT):
- Tumour close to a ureteral orifice
- Muscle in specimen
- pT1 high-grade (HG) urothelial carcinoma (UCa) + carcinoma in situ (CIS)
- Second TURBT:
- 3 papillary tumours
- Muscle in specimen
- pT1b HG UCa + CIS
- Third TURBT: no residual disease
The patient refused radical cystectomy (RC). Bacillus Calmette-Guérin (BCG) instillations for up to 3 years are planned.